Cleavage of BCR–ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR–ABL leukemic cells

Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown

(2011) Soo-Ryoon Ryoo et al.   BIOMATERIALS

Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib

(2010) M. Koldehoff et al.   HAEMATOLOGICA

RelB-Dependent Differential Radiosensitization Effect of STI571 on Prostate Cancer Cells

(2010) Yong Xu et al.   MOLECULAR CANCER THERAPEUTICS

Suppression of Hepatitis C Virus Genome Replication in Cells with RNA-Cleaving DNA Enzymes and Short-Hairpin RNA

(2010) Bokhui Lee et al.   OLIGONUCLEOTIDES

Resistance to Imatinib: Mutations and Beyond

(2010) Paul La Rosée et al.   SEMINARS IN HEMATOLOGY

Imatinib and beyond—exploring the full potential of targeted therapy for CML

(2009) Alfonso Quintás-Cardama et al.   Nature Reviews Clinical Oncology

Deoxyribozymes: useful DNA catalysts in vitro and in vivo

(2008) D. A. Baum et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase

(2007) Kyoung Jin Jang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS